Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARTEM: PAE vs Medical Treatment in BPH
NCT02869971Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2016
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: International Prostate Symptom Score at 9 months. Started Aug 2016; status: completed.
Beyond the preview
Go deeper on NCT02869971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02869971.